Tags

Type your tag names separated by a space and hit enter

[Polypous rhinosinusitis in the context of the asthma triad].
Vestn Otorinolaringol. 2011VO

Abstract

The present study included 37 patients at the age from 18 to 65 years suffering polypous rhinosinusopathy (PRS). Endoscopic examination of their nasal cavity and anterior rhinoscopy revealed the presence of large- and medium-sized polyps (stages II-III according to the classification of G.M. Portenko).. All the patients were treated with longidase either injected directly into the polyps at a dose of 3,000 IU or used to irrigate the affected nasal mucosa (10 seances). Positive effect of the treatment was documented in 32 (86%) patients of both groups who reported restoration of nasal breathing, showed improved functional characteristics, and significantly reduced size of local polyps upon the endoscopic examination of the nasal cavity. It is concluded that longidase is an efficacious and safe preparation for the conservative treatment of polypous rhinosinusitis.

Authors

Tsyvkina AA
No affiliation info available
Tsarev SV
No affiliation info available

MeSH

Administration, IntranasalAdolescentAdultAgedAnti-Inflammatory Agents, Non-SteroidalAsthmaChronic DiseaseEndoscopyFemaleHumansInjections, IntralesionalMaleMiddle AgedNasal PolypsRhinitisSinusitisTreatment OutcomeYoung Adult

Pub Type(s)

Comparative Study
English Abstract
Journal Article

Language

rus

PubMed ID

21378746

Citation

Tsyvkina, A A., and S V. Tsarev. "[Polypous Rhinosinusitis in the Context of the Asthma Triad]." Vestnik Otorinolaringologii, 2011, pp. 77-80.
Tsyvkina AA, Tsarev SV. [Polypous rhinosinusitis in the context of the asthma triad]. Vestn Otorinolaringol. 2011.
Tsyvkina, A. A., & Tsarev, S. V. (2011). [Polypous rhinosinusitis in the context of the asthma triad]. Vestnik Otorinolaringologii, (1), 77-80.
Tsyvkina AA, Tsarev SV. [Polypous Rhinosinusitis in the Context of the Asthma Triad]. Vestn Otorinolaringol. 2011;(1)77-80. PubMed PMID: 21378746.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Polypous rhinosinusitis in the context of the asthma triad]. AU - Tsyvkina,A A, AU - Tsarev,S V, PY - 2011/3/8/entrez PY - 2011/3/8/pubmed PY - 2011/7/6/medline SP - 77 EP - 80 JF - Vestnik otorinolaringologii JO - Vestn. Otorinolaringol. IS - 1 N2 - The present study included 37 patients at the age from 18 to 65 years suffering polypous rhinosinusopathy (PRS). Endoscopic examination of their nasal cavity and anterior rhinoscopy revealed the presence of large- and medium-sized polyps (stages II-III according to the classification of G.M. Portenko).. All the patients were treated with longidase either injected directly into the polyps at a dose of 3,000 IU or used to irrigate the affected nasal mucosa (10 seances). Positive effect of the treatment was documented in 32 (86%) patients of both groups who reported restoration of nasal breathing, showed improved functional characteristics, and significantly reduced size of local polyps upon the endoscopic examination of the nasal cavity. It is concluded that longidase is an efficacious and safe preparation for the conservative treatment of polypous rhinosinusitis. SN - 0042-4668 UR - https://www.unboundmedicine.com/medline/citation/21378746/[Polypous_rhinosinusitis_in_the_context_of_the_asthma_triad]_ L2 - http://www.diseaseinfosearch.org/result/633 DB - PRIME DP - Unbound Medicine ER -